MonoSol Rx to Present at 2015 American Association of Pharmaceutical Scientists Annual Exposition Demonstrating PharmFilm as a Bioequivalent Delivery Platform for Sildenafil Citrate
October 21, 2015 16:35 ET
|
MonoSol Rx
WARREN, N.J., Oct. 21, 2015 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® drug delivery technology to develop treatments that improve patient...
MonoSol Rx Leadership Presents Data Supporting PharmFilm Technology Effective for Oral Peptide Delivery
October 19, 2015 16:15 ET
|
MonoSol Rx
WARREN, N.J., Oct. 19, 2015 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® drug delivery technology to develop treatments that improve patient...
MonoSol Rx Partner Galena Biopharma Launches Zuplenz(R) (Ondanestron) Oral Soluble Film
August 05, 2015 10:03 ET
|
MonoSol Rx
WARREN, N.J., Aug. 5, 2015 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® drug delivery technology to develop treatments that improve patient...
MonoSol Rx Announces Initiation of Phase 2a Trial for Oral Insulin Film
July 27, 2015 15:01 ET
|
MonoSol Rx
Midaform® Insulin PharmFilm® delivers Insulin through Buccal Soluble Film
WARREN, N.J., July 27, 2015 (GLOBE NEWSWIRE) -- MonoSol Rx, the developer of PharmFilm drug delivery technology,...
MonoSol Rx Leadership Presented PharmFilm Buccal Delivery Clinical Update at Leading Pharmaceutical Technology Meeting
February 09, 2015 08:00 ET
|
MonoSol Rx
WARREN, N.J., Feb. 9, 2015 (GLOBE NEWSWIRE) -- MonoSol Rx, the developer of PharmFilm® drug delivery technology, presented the Company's technology recently at the International Association for...
MonoSol Rx Names A. Mark Schobel Chief Innovation & Technology Officer; Keith Kendall Assumes Role of CEO
December 17, 2014 09:58 ET
|
MonoSol Rx
WARREN, N.J., Dec. 17, 2014 (GLOBE NEWSWIRE) -- MonoSol Rx, the developer of PharmFilm® drug delivery technology, today announced that Keith Kendall will assume the role of Chief Executive...
US Patent Office Institutes Inter Partes Review Brought by MonoSol Rx Against All Claims in Key BDSI BEMA Patent
October 06, 2014 09:35 ET
|
MonoSol Rx
WARREN, N.J., Oct. 6, 2014 (GLOBE NEWSWIRE) -- The United States Patent and Trademark Office (USPTO) has granted MonoSol Rx, LLC's (MonoSol Rx) petition for inter partes review (IPR) of all claims of...
MonoSol Rx Launches Clinical Study of MSRX-110 Oral Film for Testosterone Replacement
August 18, 2014 08:30 ET
|
MonoSol Rx
WARREN, N.J., Aug. 18, 2014 (GLOBE NEWSWIRE) -- MonoSol Rx, the developer of PharmFilm® drug delivery technology, today announced that it has begun enrolling patients with hypogonadism in an...
MonoSol Rx Enters Into Exclusive Licensing Agreement With Galena Biopharma for Zuplenz(R) Oral Soluble Film
July 22, 2014 07:15 ET
|
MonoSol Rx
WARREN, N.J., July 22, 2014 (GLOBE NEWSWIRE) -- MonoSol Rx, the developer of PharmFilm® drug delivery technology, today announced that it has licensed Zuplenz® (ondansetron) to Galena...
MonoSol Rx Appoints Joseph Crusco Director of Business Development
July 10, 2014 08:30 ET
|
MonoSol Rx
WARREN, N.J., July 10, 2014 (GLOBE NEWSWIRE) -- MonoSol Rx, the developer of PharmFilm® drug delivery technology, today announced the appointment of Joseph Crusco to the position of Director,...